CHRS

Coherus BioSciences (CHRS)

About Coherus BioSciences (CHRS)

Coherus BioSciences, Inc. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of biosimilar therapeutics. Its products include UDENYCA and LOQTORZI. The company was founded by Dennis M. Lanfear, Stuart E. Builder, Dr. Alan Herman, Doug Farrar and Steve Glover in September 2010 and is headquartered in Redwood City, CA.

Details

Daily high
$0.83
Daily low
$0.76
Price at open
--
52 Week High
$2.43
52 Week Low
$0.66
Market cap
92.7M
Dividend yield
0.00%
Volume
44
Avg. volume
1.8M
P/E ratio
-.71

Coherus BioSciences News

Details

Daily high
$0.83
Daily low
$0.76
Price at open
--
52 Week High
$2.43
52 Week Low
$0.66
Market cap
92.7M
Dividend yield
0.00%
Volume
44
Avg. volume
1.8M
P/E ratio
-.71